The invention refers to the use of an engineered 'Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR)-CRISPR associated (Cas)’ (CRISPR-Cas) technology targeting a sequence mutated at one or more loci in the genome of a given eukaryotic cell
The compounds of the present invention are pyrazole[4,3-b]pyridin-6-carboxamide derivatives characterised by direct antibacterial activity against several Gram-positive bacteria
The present invention represents an in vitro implementable method and related kit for assessing the response to immune tolerance restoration therapy by evaluating the expression of specific microRNAs (miRNAs) as biomarkers of residual beta-cell function.
The present invention consists of an electromechanical stimulation system, and related wearable device, generating and transmitting mechanical vibrations to the bone processes near a user's ear.
The invention concers compounds that act directly on the extracellular virus.
The invention consists of alternative compounds to nitisinone, for the treatment of both AKU and HT1.
The present invention serves the development of new therapeutic strategies and new non-opioid drugs for the treatment of pain
The purpose of this invention is to provide a biological housing system capable of undergoing highly controlled ultrasonic stimulations, capable of guaranteeing, at the same time, practicality and simplicity of use, low cost and complete sterility of the biological samples tested
This invention makes it possible to study in depth the phenomena involved in the ultrasonic stimulation of living materials and cells, thus paving the way for the optimisation of these stimulation processes in numerous areas
The invention relates to a device for detecting the position and movement of a human limb through a plurality of sensors and a unit that manages the data and the respective flow.
